Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonerosive Reflux Disease”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableUnknownNCT02490449
What this trial is testing

Dexlansoprazole MR in Nonerosive Reflux Disease

Who this might be right for
Nonerosive Reflux Disease
Soonchunhyang University Hospital 356
Testing effectiveness (Phase 2)UnknownNCT05312463
What this trial is testing

Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome

Who this might be right for
Gastroesophageal RefluxFunctional Dysphonia
Xiyuan Hospital of China Academy of Chinese Medical Sciences 228
Large-scale testing (Phase 3)Study completedNCT01065649
What this trial is testing

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients

Who this might be right for
Gastroesophageal Reflux Disease
Universidade de Passo Fundo 20
Testing effectiveness (Phase 2)Looking for participantsNCT02616302
What this trial is testing

Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Takeda 70
Not applicableUnknownNCT00155805
What this trial is testing

Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus

Who this might be right for
Reflux EsophagitisHiatal Hernia
National Taiwan University Hospital 90
Large-scale testing (Phase 3)Study completedNCT00321984
What this trial is testing

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 947
Very early researchUnknownNCT04324138
What this trial is testing

Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease

Who this might be right for
Nonerosive Reflux Disease
Xiyuan Hospital of China Academy of Chinese Medical Sciences 78
Large-scale testing (Phase 3)Study completedNCT02873689
What this trial is testing

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

Who this might be right for
HeartburnGastroesophageal Reflux Disease
Takeda 217
Not applicableUnknownNCT03068572
What this trial is testing

Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD

Who this might be right for
Gastroesophageal Reflux DiseaseMinimal Change DiseaseNon-Reflux Esophagitis
Affiliated Hospital to Academy of Military Medical Sciences 90
Large-scale testing (Phase 3)UnknownNCT04340297
What this trial is testing

Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

Who this might be right for
Nonerosive Reflux Disease
Xiyuan Hospital of China Academy of Chinese Medical Sciences 180
Not applicableStudy completedNCT03436914
What this trial is testing

Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease

Who this might be right for
Non-erosive Gatroesophageal Reflux Disease
Yonsei University 62
Early research (Phase 1)Study completedNCT01095133
What this trial is testing

Do Acid Sensing Ion Channels Contribute to Heartburn?

Who this might be right for
Gastroesophageal Reflux DiseaseHeartburn
University of North Carolina, Chapel Hill 24
Early research (Phase 1)Study completedNCT06391177
What this trial is testing

Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

Who this might be right for
Erosive EsophagitisHeartburnSymptomatic Nonerosive Gasroesophageal Reflux Disease+1 more
Phathom Pharmaceuticals, Inc. 15